Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLDX | AAPG | SRPT | ||
| Company | Celldex Therapeutics | Ascentage Pharma Group Intl ADR | Sarepta Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 35.79 | 26.39 | 21.38 | ||
| High | 35.79 | 26.40 | 21.49 | ||
| Low | 34.34 | 26.35 | 20.81 | ||
| Latest | 34.38 | 26.36 | 21.42 | ||
| Change | -0.17 | -1.04 | -0.13 | ||
| % Change | -0.49% | -3.80% | -0.60% | ||
| Volume | 943,300 | 1,900 | 2,807,300 | ||
| 20-Day Average Volume | 1,262,330 | 3,730 | 3,491,840 | ||
| Previous Close | 34.55 | 27.40 | 21.55 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 32.19 | 25.02 | 21.47 | ||
| 20-Day Raw Stochastic | 80.89% | 80.99% | 66.16% | ||
| 20-Day Relative Strength | 63.20 | 54.01 | 54.04 | ||
| Weighted Alpha | +60.07 | -8.26 | -16.62 | ||
| Today's Opinion | 100% Buy | 40% Sell | 40% Buy | ||
| Previous Opinion | 100% Buy | 24% Sell | 56% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.49% since 04/13/26 | +3.58% since 04/13/26 | -1.70% since 04/13/26 | ||
| Low | 31.97 on 04/14/26 | 25.69 on 04/14/26 | 20.76 on 04/16/26 | ||
| High | 35.79 on 04/20/26 | 27.40 on 04/17/26 | 22.49 on 04/15/26 | ||
| 1-Month | |||||
| %Chg | +11.26% since 03/20/26 | +37.94% since 03/20/26 | +28.34% since 03/20/26 | ||
| Low | 28.41 on 04/02/26 | 21.16 on 03/23/26 | 16.67 on 03/23/26 | ||
| High | 35.79 on 04/20/26 | 28.06 on 04/06/26 | 23.85 on 03/25/26 | ||
| 3-Month | |||||
| %Chg | +36.75% since 01/20/26 | +1.35% since 01/20/26 | +1.81% since 01/20/26 | ||
| Low | 22.33 on 02/06/26 | 19.11 on 03/20/26 | 15.52 on 03/06/26 | ||
| High | 35.79 on 04/20/26 | 28.06 on 04/06/26 | 24.68 on 01/26/26 | ||
| 6-Month | |||||
| %Chg | +24.25% since 10/20/25 | -25.35% since 10/20/25 | -7.07% since 10/20/25 | ||
| Low | 22.10 on 11/11/25 | 19.11 on 03/20/26 | 15.08 on 11/04/25 | ||
| High | 35.79 on 04/20/26 | 35.49 on 10/22/25 | 24.68 on 01/26/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,288,539 | 2,460,205 | 2,248,886 | ||
| Shares Outstanding, K | 66,566 | 93,331 | 104,990 | ||
| Annual Sales | 1,550,000 | 82,100,000 | 2,198,240,000 | ||
| Annual Net Income | -258,760,000 | -177,710,000 | -713,410,000 | ||
| Last Quarter Sales | 120,000 | N/A | 442,930,000 | ||
| Last Quarter Net Income | -81,320,000 | N/A | -282,850,000 | ||
| 60-Month Beta | 1.19 | 0.79 | 0.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.22 on 02/25/26 | N/A | -3.58 on 02/25/26 | ||
| Latest Earnings Date | 05/14/26 | 03/25/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||